SCHIZO AFFECTIVE DISORDER
Clinical trials for SCHIZO AFFECTIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new SCHIZO AFFECTIVE DISORDER trials appear
Sign up with your email to follow new studies for SCHIZO AFFECTIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study matches Weight-Loss drugs to bipolar Patients' unique biology
Disease control Recruiting nowThis study tests whether matching weight-loss medications to a person's specific obesity type (like 'hungry brain' or 'emotional hunger') helps people with bipolar disorder lose weight safely. About 100 adults aged 18-65 will take one of three FDA-approved drugs or join a weight-…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
New shock therapy aims to stop suicidal thoughts with less memory loss
Symptom relief Recruiting nowThis study compares a new, lower-energy seizure therapy (LAP-ST) to standard electroconvulsive therapy (ECT) for quickly reducing suicidal thoughts in people with depression, bipolar disorder, or schizoaffective disorder. About 30 adults will receive one of the two treatments. Th…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE2, PHASE3 • Sponsor: Michigan State University • Aim: Symptom relief
Last updated May 17, 2026 00:52 UTC
-
Could a common allergy drug help schizophrenia?
Symptom relief Recruiting nowThis study tests whether cromoglicate, a drug used for allergies, can improve symptoms of schizophrenia when taken alongside standard medication. Researchers will enroll 160 adults aged 18-60 with schizophrenia or schizoaffective disorder. Participants will receive either cromogl…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Vishwajit Nimgaonkar, MD PhD • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New drug aims to soothe severe agitation in kids with mental health conditions
Symptom relief Recruiting nowThis study tests an experimental medicine called BXCL501 to see if it can safely reduce sudden severe agitation in children aged 10-17 with schizophrenia or bipolar disorder. About 140 participants will receive either the drug or a placebo. The goal is to quickly calm symptoms li…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE1 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated May 11, 2026 20:53 UTC
-
Could a common drug help when schizophrenia treatments fail?
Symptom relief Recruiting nowThis study tests whether adding acetazolamide to standard antipsychotic medication can reduce symptoms in people with treatment-resistant schizophrenia. About 60 adults aged 18-55 will receive either acetazolamide or a placebo for a set period, while continuing their usual medica…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: PHASE1, PHASE2 • Sponsor: Vishwajit Nimgaonkar, MD PhD • Aim: Symptom relief
Last updated May 11, 2026 20:48 UTC
-
Virtual reality could boost brain power for people with psychosis
Symptom relief Recruiting nowThis study tests a virtual reality program designed to help people with psychosis improve their thinking and social skills. About 52 adults aged 18-60 with stable psychosis will use the program and do homework. The goal is to see if it's practical and helpful for daily life.
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: The Royal Ottawa Mental Health Centre • Aim: Symptom relief
Last updated Apr 29, 2026 15:04 UTC
-
Brain wave study seeks early clues to psychosis
Knowledge-focused Recruiting nowThis study looks at how the brain processes visual information in people with schizophrenia, bipolar disorder, or schizoaffective disorder. Researchers will use EEG to measure brain activity while participants view images. The goal is to find early markers of psychosis that could…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated May 17, 2026 00:44 UTC
-
Zapping the brain to read faces: new hope for schizophrenia?
Knowledge-focused Recruiting nowThis study looks at whether a gentle, non-invasive brain stimulation technique called tDCS can improve the ability to recognize emotions on people's faces in those with schizophrenia. Researchers will use brain scans (fMRI) and brain wave recordings (EEG) to see how the brain res…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: Nathan Kline Institute for Psychiatric Research • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Scientists use magnetic pulses to map hallucinations in the brain
Knowledge-focused Recruiting nowThis study uses a safe, noninvasive technique called transcranial magnetic stimulation (TMS) to understand how hallucinations happen in people with schizophrenia or schizoaffective disorder. Researchers will stimulate a specific brain circuit and measure changes in brain activity…
Matched conditions: SCHIZO AFFECTIVE DISORDER
Phase: NA • Sponsor: Mclean Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC